Denovo Biopharma
Ms. Carrie Chen has more than 20 years of experience in the financial industry. Prior to joining Denovo Biopharma, Ms. Chen served as Asia-Pacific Leading Partner in Life-Science & Healthcare industry in Deloitte and worked in the investment banking department of CITIC Securities / CLSA (Hong Kong), as well as Deloitte New York and Taiwan. Ms. Chen holds MBA in leveraged buyout and corporate strategy from the Wharton School of the University of Pennsylvania.
This person is not in any offices
Denovo Biopharma
Denovo Biopharma is a private San Diego-based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.